experimental phage 88 is not routinely used for typing in U.S. laboratories, the nationwide distribution of strains of type 88 is difficult to assess.
There are few data available concerning the regional epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) strains (6, 12, 13) . Data from the general population refer mainly to drug addicts (14) , whereas data regarding hospital outbreaks, in most instances, refer to individual hospitals (3, (7) (8) (9) (10) (11) or hospital services, especially burn units (5) . In New York City, the Staphylococcus Phage Typing Unit of the Bureau of Laboratories receives specimens for phage typing from most hospitals in the city. In addition, hospitals are requested to send MRSA isolates as part of a long-term survey of the incidence of MRSA strains in New York City hospitals, thus allowing us to follow from inception the emergence of MRSA strains in these hospitals. This survey began in 1977 when the first MRSA strains were received by our laboratory. Initially (1977 to 1978) , we received strains of phage type 92 from six hospitals (17), with a relatively large number of isolates at two hospitals. In 1979 to 1980, the number of hospitals with MRSA strains increased to 10 resistance on agar plates with 10 ,ug each of methicillin and gentamicin per ml. Representative MRSA strains and, in some instances, methicillin-susceptible isolates of the same phage type as the MRSA strains were tested in the same manner as in previous surveys (3, 16, 17) for susceptibility to each of the following: amikacin, chloramphenicol, clindamycin, erythromycin, gentamicin, penicillin, rifampin, tetracycline, trimethoprim-sulfamethoxazole, and vancomycin.
Phage susceptibility. All strains were tested for phage susceptibility with the international set of S. aureus phages and an additional set of experimental phages routinely used in our laboratory (4, 16) . The international phages were used at routine test dilution concentration and, in some instances, at 100x routine test dilution. The experimental phages were used at 100x routine test dilution concentration.
Biochemical tests. Acid production from mannitol and growth response was tested on mannitol salt agar plates (Difco). The same medium with 0.9% NaCl and 1% mannitol or 1% lactose was used for additional carbohydrate tests.
Plasmid DNA electrophoresis was performed in the same manner as previously described (15) , except that the lysostaphin concentration was increased to 100 ,ug/ml, and the cells were kept for 5 min at room temperature after the addition of 1% dodecyl sulfate in 0.2 M NaOH.
RESULTS
Distribution of methicillin-resistant strains. (15 hospitals) . MRSA strains of type 88 tended to persist at hospitals from which we received at least 20 isolates, being consistently the main group of MRSA strains received from these hospitals. In several instances, the incidence of type 88 strains was reduced by isolation and cohorting of patients, but they were never completely eradicated.
Variations in antibiotic and phage susceptibility. Strains of type 85, 81, and 208, which are susceptible to methicillin, were isolated at the same hospitals in which methicillinresistant strains of the same phage type were isolated. Methicillin-susceptible strains retained gentamicin resistance and were mannitol negative. Strains susceptible to phage 84 (group III) were isolated at the same hospitals in which strains of type 88 were isolated. These strains exhibited the resistance spectrum of type 88 strains, including rifampin resistance and were susceptible to experimental phages 88 or 88, 89, and 92. Some strains also became susceptible to phages 83A and 85. The strains carried a very large plasmid and a small chloramphenicol plasmid characteristic for strains type 88 (15) and did not produce acid from lactose. In mixed culture with strain 766, these strains acquired phage-mediated novobiocin resistance (15) . This appears to indicate that some MRSA strains classified as belonging to the international phage group III are closely related to strains of type 88.
Both clinical isolates and in vitro derivatives of strains of type 88 were obtained which lost gentamicin and clindamycin or methicillin and cadmnium resistance. These susceptible derivatives showed no detectable changes in their plasmid DNA electrophoretic pattern or phage susceptibility. Chloramphenicol-susceptible derivatives lacked the small chloramphenicol plasmid. We obtained in vitro and also from cul- tures of type 88 received from two hospitals susceptible isolates which retained resistance to penicillin and tetracycline and, in several instances, resistance to streptomycin and clindamycin. These strains were characterized by the appearance of at least three additional plasmids, possibly originating from the very large plasmid present in strains of type 88. They became susceptible to a large number of phages of groups I and III as well as several experimental phages. Their lysogenic phage had the same host spectrum as phage 188 present in stralns of type 88 and promoted acquisition of novobiocin resistance from strains of type 766 (15) . These strains are presently under investigation.
DISCUSSION
Large urban centers such as New York City pose specific epidemiological problems due to the size and mobility of their population and the concentration in a limited area of a sizable number of large health care facilities. Under these circumstances, the inter-hospital spread of nosocomial infections can be of epidemiological significance. In the case of MRSA strains, the investigation of inter-hospital transfer of MRSA strains is facilitated by the existence of a central phage typing facility. This organizational setup imposes certain limitations in the interpretation of our data. Large hospitals with well-staffed epidemiological control services are probably overrepresented in this survey.
The factors affecting the inter-hospital spread of MRSA strains are only partly understood. Among them are common medical staff in affiliated hospitals, prior hospitalization of patients in hospitals with endemic MRSA strains, and the spread of resistant strains among drug addicts (14) . A still unknown factor is the prevalence of MRSA strains in the general population. A preliminary inVestigation of S. aureus strains isolated at pediatric clinics yielded no methicillinresistant strains among the 400 strains tests (S. Schaefler, unipublished data).
A comparison of phage types and resistance patterns of MRSA strains isolated in New York City over a period of 6 years indicated major shifts in jboth the predominant phage types and resistance spectra. The first methicillin-resistant strains received by our laboratory were of experimental phage type 92 (17). The strains of type 92 were predominantly gentamicin susceptible. During a subsequent survey in 1979 to 1980 (16) , strains of type 92 were replaced by other phage types at each of the hospitals in which they were initially isolated, mostly by gentatnicin-resistant MRSA strains. In contrast to the strains isolated in 1977 to 1978, the strains isolated in 1979 to 1980 showed a variety of phage susceptibility patterns, with sorhe of the hospitals having characteristic endemic strains. At that time, there was apparently only a limited inter-hospital spread of MRSA strains.
The main epidemiological feature observed in 1982 to 1983 was the presence of strains of the same phage type at several hospitals, especially the emergence of strains of type 88 as the main MRSA isolate at a large number of hospitals. The consistent presence of rifampin resistance, lysogeny for phage 188, and the small chloramphenicol plasmid (15) in all strains tested in this respect seems to indicate a common origin of these strains. The causes for the spread of strains of type 88 are difficult to assess. Contributing factors could be the tendency of these strains to persist in the hospital environment. As our laboratory is apparently the only Public Health Laboratory in the United States using phage 88 for S. aureus phage typing, it could be interesting to ascertain the incidence of MRSA strains of type 88 among "nontypable" strains isolated in other regions of the United States.
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